Status:
COMPLETED
Effect of Brivaracetam in Photosensitive Epileptic Subjects
Lead Sponsor:
UCB Pharma
Conditions:
Epilepsy
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
to assess the effect of brivaracetam on the photoparoxysmal EEG response in photosensitive epileptic subjects
Eligibility Criteria
Inclusion
- epileptic subjects with generalized PPR
Exclusion
- more than 2 concomitant antiepileptic drugs
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
End Date :
June 1 2003
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00401648
Start Date
September 1 2002
End Date
June 1 2003
Last Update
December 1 2009
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Marseille, France
2
Paris, France
3
Rouen, France
4
Strasbourg, France